Immediate Impact

2 by Nobel laureates 10 from Science/Nature 60 standout
Sub-graph 1 of 23

Citing Papers

Synthetic Glycans to Improve Current Glycoconjugate Vaccines and Fight Antimicrobial Resistance
2022 Standout
Designing antibodies as therapeutics
2022 Standout
2 intermediate papers

Works of Michael Collins being referenced

Safety, Pharmacokinetics, and Functional Activity of Human Anti-Pseudomonas aeruginosa Monoclonal Antibodies in Septic and Nonseptic Patients
1991
Protective activity of an intravenous immune globulin (human) enriched in antibody against lipopolysaccharide antigens of Pseudomonas aeruginosa
1984

Author Peers

Author Last Decade Papers Cites
Michael Collins 1178 615 619 105 2.3k
W. David Wilson 828 295 481 134 3.7k
Seung‐Yong Park 851 678 1207 169 3.9k
Eduardo Ortega‐Barría 982 320 1100 107 3.8k
Jan Paeshuyse 595 160 549 93 2.5k
Robert L. Flower 459 111 461 178 2.6k
Paul Liberator 1073 268 807 73 3.3k
Fausto G. Araujo 2722 114 323 114 4.0k
Kaoru Takeuchi 2161 326 813 98 3.3k
Fabrice Laurent 329 502 743 93 2.6k
C. Cocito 1131 58 988 140 2.9k

All Works

Loading papers...

Rankless by CCL
2026